Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
language:"Undetermined"
format_facet:"Aufsätze"
topic_facet:"Phase: Phase 3"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=language%3A%22Undetermined%22&filter%5B%5D=format_facet%3A%22Aufs%C3%A4tze%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22&lookfor=Dexamethasone+OR+corticosteroid&type=AllFields&page=3
/vufind/Search/Results?filter%5B%5D=language%3A%22Undetermined%22&filter%5B%5D=format_facet%3A%22Aufs%C3%A4tze%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22&lookfor=Dexamethasone+OR+corticosteroid&type=AllFields&page=3
Search /vufind/Search2/Results?filter%5B%5D=language%3A%22Undetermined%22&filter%5B%5D=format_facet%3A%22Aufs%C3%A4tze%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22&lookfor=Dexamethasone+OR+corticosteroid&type=AllFields&page=3
PubPharm (30)
21
A Phase 3 Study of Elranatamab (PF-06863135) Monotherapy and Elranatamab + Daratumumab Versus Daratumumab + Pomalidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma : AN OPEN-LABEL, 3-ARM, MULTICENTER, RANDOMIZED PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ELRANATAMAB (PF-06863135) MONOTHERAPY AND ELRANATAMAB + DARATUMUMAB VERSUS DARATUMUMAB + POMALIDOMIDE + DEXAMETHASONE IN PARTICIPANTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA WHO HAVE RECEIVED AT LEAST 2 PRIOR LINES OF THERAPY INCLUDING LENALIDOMIDE AND A PROTEASOME INHIBITOR
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
22
A Phase 3 Study of Elranatamab (PF-06863135) Monotherapy and Elranatamab + Daratumumab Versus Daratumumab + Pomalidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma : AN OPEN-LABEL, 3-ARM, MULTICENTER, RANDOMIZED PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ELRANATAMAB (PF-06863135) MONOTHERAPY AND ELRANATAMAB + DARATUMUMAB VERSUS DARATUMUMAB + POMALIDOMIDE + DEXAMETHASONE IN PARTICIPANTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA WHO HAVE RECEIVED AT LEAST 2 PRIOR LINES OF THERAPY INCLUDING LENALIDOMIDE AND A PROTEASOME INHIBITOR
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
23
Randomized Phase 3 study of Pomalidomide-Cyclophosphamide-Dexamethasone (PCD) versus Pomalidomide-Dexamethasone (PD) in relapse or refractory myeloma. An AMN study : Randomized Phase 3 study of Pomalidomide-Cyclophosphamide-Dexamethasone (PCD) versus Pomalidomide-Dexamethasone (PD) in relapse or refractory myeloma. An AMN study
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
24
Randomized Phase 3 study of Pomalidomide-Cyclophosphamide-Dexamethasone (PCD) versus Pomalidomide-Dexamethasone (PD) in relapse or refractory myeloma. An AMN study : Randomized Phase 3 study of Pomalidomide-Cyclophosphamide-Dexamethasone (PCD) versus Pomalidomide-Dexamethasone (PD) in relapse or refractory myeloma. An AMN study
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
25
CeMyLungs : A 3 year randomised, open label, multi-centre Investigator driven study comparing de Novo enteric coated Mycophenolate Sodium with delayed onset Everolimus, both arms in combination with Cyclosporin (using C2 monitoring) and Corticosteroids for the prevention of Bronchiolitis Obliterans Syndrome in Heart-Lung, Bilateral Lung and Single Lung Transplant recipients.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
26
CeMyLungs : A 3 year randomised, open label, multi-centre Investigator driven study comparing de Novo enteric coated Mycophenolate Sodium with delayed onset Everolimus, both arms in combination with Cyclosporin (using C2 monitoring) and Corticosteroids for the prevention of Bronchiolitis Obliterans Syndrome in Heart-Lung, Bilateral Lung and Single Lung Transplant recipients.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
27
Dexamethasone in Herpes Simplex Virus Encephalitis Trial : Dexamethasone in Herpes Simplex Virus Encephalitis Open label Randomized Controlled Trial with an Observer-blinded evaluation at 6 months - DexEnceph
enthalten in:
WHO International Clinical Trials Registry Platform
| 2017
Wird geladen...
28
Dexamethasone in Herpes Simplex Virus Encephalitis Trial : Dexamethasone in Herpes Simplex Virus Encephalitis Open label Randomized Controlled Trial with an Observer-blinded evaluation at 6 months - DexEnceph
enthalten in:
WHO International Clinical Trials Registry Platform
| 2017
Wird geladen...
29
Lumbar epidural steroids. : Efficacy and safety of epidural administration of betamethasone and dexamethasone by caudal route for the treatment of radicular pain: randomized clinical trial.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2016
Wird geladen...
30
Lumbar epidural steroids. : Efficacy and safety of epidural administration of betamethasone and dexamethasone by caudal route for the treatment of radicular pain: randomized clinical trial.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2016
Wird geladen...
[1]
« Vorheriger
1
2
3
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Sprache: Unbestimmt
Filter aufheben
Medienart: Aufsätze
Filter aufheben
Thema: Phase: Phase 3
Medienart
Aufsätze
30
E-Artikel
30
E-Ressourcen
Zeitschriftentitel
30
WHO International Clinical Trials Registry Plat...
Thema
30
610
Phase: Phase 3
30
Study Type: Interventional
22
Recruitment Status: Authorised-recruitment may ...
16
Medical Condition: MULTIPLE MYELOMA MedDRA vers...
4
Recruitment Status: Not yet recruiting
2
Medical Condition: ;Diseases of the blood and b...
2
Medical Condition: HSV encephalitis MedDRA vers...
2
Medical Condition: Health Condition 1: C15-C26-...
2
Medical Condition: Health Condition 1: G409- Ep...
2
Medical Condition: Heart Lung, Bilateral Lung a...
2
Medical Condition: Multiple myeloma MedDRA vers...
2
Medical Condition: radiculalgia;Therapeutic are...
2
Recruitment Status: Completed
2
Recruitment Status: Recruiting
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
26
2020-
4
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
Unbestimmt
Haven't found what you're looking for?
Wird geladen...